Published in Pathology on January 01, 1983
Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol (1986) 9.90
In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents. Antimicrob Agents Chemother (1985) 1.88
Comparison of antimicrobial susceptibility patterns of Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1984) 1.67
Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility. Antimicrob Agents Chemother (1989) 1.29
Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds. Antimicrob Agents Chemother (1985) 1.25
In vitro activities of 47 antimicrobial agents against three Campylobacter spp. from pigs. Antimicrob Agents Chemother (1985) 1.17
In vitro susceptibilities of aerotolerant Campylobacter isolates to 22 antimicrobial agents. Antimicrob Agents Chemother (1992) 0.84
Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med (1982) 3.45
Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol (2001) 3.02
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis (1995) 2.59
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients. Cochrane Database Syst Rev (2006) 2.13
Depression of immunological function in patients treated with phenytoin sodium (sodium diphenylhydantoin). Lancet (1971) 1.93
Phospholipase activity in Cryptococcus neoformans: a new virulence factor? J Infect Dis (1997) 1.72
A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother (1985) 1.64
Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol (1986) 1.60
Campylobacter jejuni: incidence in processed broilers and biotype distribution in human and broiler isolates. Appl Environ Microbiol (1982) 1.56
Three-year experience with neonatal ventilation from a tertiary care hospital in Delhi. Indian Pediatr (1993) 1.51
Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun (1997) 1.45
Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro. Clin Exp Immunol (1975) 1.40
Campylobacter jejuni in broilers: the role of vertical transmission. J Hyg (Lond) (1986) 1.38
Cryptococcosis: clinical and biological aspects. Med Mycol (2000) 1.35
Disseminated candidiasis: evidence of a distinctive syndrome in heroin abusers. Br Med J (Clin Res Ed) (1983) 1.31
Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect (2009) 1.28
Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection. Clin Microbiol Infect (2009) 1.24
Cryptococcus neoformans var. gattii infection in northern Australia: existence of an environmental source other than known host eucalypts. Trans R Soc Trop Med Hyg (1998) 1.23
Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience. Transpl Infect Dis (2009) 1.22
Course of bipolar disorder in eastern India. J Affect Disord (1992) 1.20
Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J (2000) 1.19
Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis (1997) 1.17
Characterization of Cryptococcus neoformans by random DNA amplification. Lett Appl Microbiol (1996) 1.15
Isolation of two molecular types of Cryptococcus neoformans var. gattii from insect frass. Med Mycol (2003) 1.14
Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis (1992) 1.13
Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species. J Clin Microbiol (1997) 1.12
Sequences of Citrus tristeza virus separated in time and space are essentially identical. J Virol (2000) 1.12
HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology (1992) 1.12
Horizontal transmission of Campylobacter jejuni amongst broiler chicks: experimental studies. Epidemiol Infect (1990) 1.10
The use of protein A-sepharose affinity chromatography for separation and detection of specific IgM antibody in acquired rubella infection: a comparison with absorption by staphylococci containing protein A and density gradient ultracentrifugation. J Immunol Methods (1980) 1.10
Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors. Magn Reson Med (1999) 1.08
In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother (1983) 1.06
Morphological and molecular evidence that Culex nigripalpus baculovirus is an unusual member of the family Baculoviridae. J Gen Virol (2001) 1.06
Mechanism of nonspecific macrophage-mediated cytotoxicity: evidence for lack of dependence upon oxygen. J Immunol (1978) 1.05
Biochemical and functional characterisation of secreted phospholipase activities from Cryptococcus neoformans in their naturally occurring state. J Med Microbiol (1999) 1.04
Cellulitis due to Pseudomonas putrefaciens: possible production of exotoxins. Rev Infect Dis (1991) 1.02
Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. Radiology (2001) 1.02
Identification by random amplification of polymorphic DNA of a common molecular type of Cryptococcus neoformans var. neoformans in patients with AIDS or other immunosuppressive conditions. J Infect Dis (1996) 1.02
Skull-base osteomyelitis: fungal vs. bacterial infection. Clin Microbiol Infect (2011) 1.02
Systemic sepsis and intravenous devices. A prospective survey. Med J Aust (1984) 1.01
Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol Infect Dis (2007) 1.01
In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis. Eur J Clin Microbiol (1982) 0.97
Characterizing cognitive deficits and dementia in an aging urban population in India. Int J Alzheimers Dis (2012) 0.97
Sensitivity of Gardnerella vaginalis to metabolites of metronidazole and tinidazole. Lancet (1982) 0.96
Leukotriene B4 omega-oxidation by human polymorphonuclear leukocytes is inhibited by pyocyanin, a phenazine derivative produced by Pseudomonas aeruginosa. Infect Immun (1992) 0.95
PCR fingerprinting: a convenient molecular tool to distinguish between Candida dubliniensis and Candida albicans. Med Mycol (2001) 0.94
A comparison of hospital and community-acquired infective endocarditis. Am J Cardiol (1992) 0.94
Experimental colonization of broiler chicks with Campylobacter jejuni. Epidemiol Infect (1988) 0.93
Recommendations for the treatment of established fungal infections. Intern Med J (2008) 0.93
Partial sequence analysis of the actin gene and its potential for studying the phylogeny of Candida species and their teleomorphs. Int J Syst Evol Microbiol (2001) 0.91
Is the antimicrobial removal device a cost-effective addition to conventional blood cultures? J Clin Pathol (1984) 0.91
Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008. J Hosp Infect (2010) 0.91
Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa. Med J Aust (1997) 0.90
A rapid slid coagglutination test-an alternative to the fluorescent antibody test for the identification of Neisseria gonorrhoeae. J Clin Pathol (1981) 0.90
Recombinant interleukin 4 stimulates human immunodeficiency virus production by infected monocytes and macrophages. J Gen Virol (1992) 0.90
Biliary sepsis. Reviewing treatment options. Drugs (1986) 0.90
Detection of occult Scedosporium species in respiratory tract specimens from patients with cystic fibrosis by use of selective media. J Clin Microbiol (2009) 0.89
Chitotriosidase and gene therapy for fungal infections. Cell Mol Life Sci (2009) 0.88
Pseudomonas putrefaciens bacteraemia in a peritoneal dialysis patient. Nephrol Dial Transplant (1991) 0.86
Inhibition of platelet eicosanoid metabolism by the bacterial phenazine derivative pyocyanin. Ann N Y Acad Sci (1994) 0.86
Production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by human neutrophils is inhibited by Pseudomonas aeruginosa phenazine derivatives. Infect Immun (1991) 0.86
Amebic abscess of the spleen complicated by metronidazole-induced neurotoxicity: case report. Clin Infect Dis (1994) 0.85
Infection of vascular prostheses. Aust N Z J Surg (1991) 0.85
Real-time PCR detection and quantitation of Chlamydophila psittaci in human and avian specimens from a veterinary clinic cluster. Eur J Clin Microbiol Infect Dis (2008) 0.85
A rapid method for detecting extracellular proteinase activity in Cryptococcus neoformans and a survey of 63 isolates. J Med Microbiol (2000) 0.85
Regulatory roles for the homeodomain and C2H2 zinc finger regions of Cryptococcus neoformans Ste12alphap. Mol Microbiol (2004) 0.83
A point mutation at the Miniature1 seed locus reduces levels of the encoded protein, but not its mRNA, in maize. Mol Gen Genet (2000) 0.83
Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. Intern Med J (2014) 0.81
Molecular diagnostic methods for invasive fungal disease: the horizon draws nearer? Pathology (2015) 0.81
Exogenous ocular candidiasis associated with intravenous heroin abuse. Br J Ophthalmol (1984) 0.81
Effect of pyocyanin and 1-hydroxyphenazine on the assay of lactate dehydrogenase activity. J Infect Dis (1991) 0.81
Systematic review and meta-analysis of antifungal agents for preventing fungal infections in liver transplant recipients. Eur J Clin Microbiol Infect Dis (2006) 0.81
Modulation of neutrophil superoxide response and intracellular diacylglyceride levels by the bacterial pigment pyocyanin. Infect Immun (1997) 0.81
Eicosapentaenoic acid modulates neutrophil leukotriene B4 receptor expression in cystic fibrosis. Clin Exp Immunol (1994) 0.81
GMP-140 (P-selectin) inhibits human neutrophil activation by lipopolysaccharide: analysis by proton magnetic resonance spectroscopy. Biochem Biophys Res Commun (1992) 0.80
Neurological toxicity associated with vidarabine (adenine arabinoside) therapy. Aust N Z J Med (1983) 0.80
Pneumonia with bacteraemia due to Escherichia coli. Aust N Z J Med (1981) 0.80
Antimicrobial therapy of postpartum endomyometritis. II. Prospective, randomized trial of mezlocillin versus ampicillin. Am J Obstet Gynecol (1981) 0.79
The origin of 1H NMR-visible triacylglycerol in human neutrophils. Highfatty acid environments result in preferential sequestration of palmitic acid into plasma membrane triacylglycerol. Eur J Biochem (2000) 0.79
Detection of antibodies to phospholipase B in patients infected with Cryptococcus neoformans by enzyme-linked immunosorbent assay (ELISA). Med Mycol (2005) 0.79
Divergent expression of cytotoxic and microbicidal functions of rabbit alveolar and peritoneal macrophages: effects of non-specific activation and a natural microbicidal peptide, MCP-1. Aust J Exp Biol Med Sci (1985) 0.79
Antimicrobial therapy of postpartum endomyometritis. I. Comparative susceptibility of mezlocillin and other antibiotics to genital anaerobic bacteria. Am J Obstet Gynecol (1981) 0.79
Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor? Med J Aust (1993) 0.79
Increased saturated triacylglycerol levels in plasma membranes of human neutrophils stimulated by lipopolysaccharide. J Lipid Res (1997) 0.78
Effect of caspofungin on metabolite profiles of Aspergillus species determined by nuclear magnetic resonance spectroscopy. Antimicrob Agents Chemother (2007) 0.78
Changes in cellular and plasma membrane phospholipid composition after lipopolysaccharide stimulation of human neutrophils, studied by 31P NMR. Eur J Biochem (1997) 0.78
Propionibacterium acnes infection in neurosurgical patients. Experience with high-dose penicillin therapy. Med J Aust (1986) 0.78
Endocarditis associated with prosthetic cardiac valves. Med J Aust (1990) 0.78
Antimicrobial therapy and prevention of spontaneous bacterial peritonitis. J Gastroenterol Hepatol (1993) 0.78
Extrapulmonary tuberculosis--a continuing problem in Australia. Aust N Z J Med (1987) 0.78
Subtyping of Mycobacterium avium complex (MAC) isolates by thin-layer chromatography--distribution of subtypes from patients with AIDS compared with clinically non-significant isolates. Epidemiol Infect (1994) 0.77
Comparison of human polymorphonuclear leukocytes from peripheral blood and purulent exudates by high resolution 1H MRS. Magn Reson Med (1991) 0.77
Production of metabolic products of arachidonic acid during cell-cell interactions. J Allergy Clin Immunol (1984) 0.77
Host defenses in acute pelvic inflammatory disease. I. Bacterial clearance in the murine uterus and oviduct. Am J Obstet Gynecol (1980) 0.76